ClinicalTrials.gg
CompletedNCT07162220Updated Sep 9, 2025

The Effect of a Mobile Game Application on Children With CRF

An interventional study of The clinic's routine education program and Mobile game app in Child, Only, Chronic Renal Failure in Children and Gambling, sponsored by Akdeniz University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 11 Years to 14 Years. Per ClinicalTrials.gov, last updated 2025-09-09.

Sponsored by Akdeniz University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled May 2024, registered Aug 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
11 Years to 14 Years
Sex
All
01

Study summary

The aim of this study was to investigate the effect of a mobile game application developed for children with Chronic Renal Failure (CRF) on disease management.

The study was a randomized controlled trial. The study sample consisted of 68 children diagnosed with CRF, including the Mobile application (n:34) and Control group (n:34). In the study, a mobile game was developed for children diagnosed with CRF aged 11-14 years. Data Collection Form, Clinical Parameters Follow-up Form, Information Form on Chronic Renal Failure, Healthy Lifestyle Belief Scale for Adolescents, Child's Attitude Toward His/her Disease Scale and Mobile Application Usability Scale were used to collect the data.

02

Conditions studied

  • Child, Only
  • Chronic Renal Failure in Children
  • Gambling
  • Disease
  • Management

Keywords

  • chronic renal failure
  • child
  • mobile game
  • disease management
03

In context

Gambling

158 studies on the registry are indexed under Gambling; 42 are open to participants now.

This study's enrollment of 68 is close to the median of 66 across 128 interventional studies indexed under Gambling.

Browse Gambling studies →

Lead sponsor

Akdeniz University is the lead sponsor of 297 studies on the registry; 62 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (a) 11-14 years old
  • (b) Being monitored with a diagnosis of Chronic Kidney Failure
  • (c) having the ability to read, write, and understand Turkish
  • (d) having a phone/tablet with mobile game download capability
  • (e) volunteering to participate in the study
  • (f) being willing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • (a) having mental, neurological, or communication problems
  • (b) being on hemodialysis
  • (c) communication, mental or neurological problems
  • (d) being on peritoneal dialysis
  • (e) having previously attended planned training on CRF
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
68 participants (actual)

Study arms

  • Other
    Routine application

    No procedures outside of the clinic's routine were performed on the children in the control group. As part of the clinic's routine education program, information about kidney function, CKD, nutrition, exercise, medications, and stress management is provided verbally by a nephrology clinic nurse in approximately 20 minutes. The Chronic Kidney Disease Information Form, the Healthy Lifestyle Belief Scale for Adolescents, and the Child's Attitude Toward Their Own Illness Scale were administered to the children before the education program, after the program, and at the end of the first and third months, and the relevant clinical parameters were measured.

    Other: The clinic's routine education program

  • Experimental
    Intervention

    A mobile game application was downloaded onto the phones of the children participating in the study group. Before starting the mobile game, after completing the application, and at the end of the first and third months, the Chronic Kidney Disease Information Form, the Healthy Lifestyle Belief Scale for Adolescents, and the Child's Attitude Toward Their Own Illness Scale were administered, and relevant clinical parameters were measured. At the end of the study, the Mobile Application Usability Scale was also administered.

    Device: Mobile game app

Interventions

  • OtherThe clinic's routine education program

    As part of the clinic's routine education program, information about kidney function, CKD, nutrition, exercise, medications, and stress management is provided verbally by a nephrology clinic nurse in approximately 20 minutes.

  • DeviceMobile game app

    The mobile game software developed for patients with chronic renal failure contains information for children on daily life activities such as nutrition, exercise, personal hygiene, etc.

06

What researchers measure

Primary outcomes

  1. BMI

    BMI in kg/m\^2

    Time frame: 3 months

  2. Blood pressure

    Time frame: 3 months

  3. Pulse rate

    Time frame: 3 months

  4. Level of knowledge regarding chronic renal failure

    The information form consists of 25 questions. The information form has been created with two answers, correct and incorrect. Correct answers are worth 1 point, while incorrect answers are worth 0 points, and the form is evaluated based on the total score. A reliability analysis was performed using Kuder Richardson 20 (KR-20) to evaluate whether the items that make up the question form form a whole.

    Time frame: 3 months

  5. Healthy Lifestyle Belief Level for Adolescents

    The scale emphasizes beliefs related to various aspects of maintaining a healthy lifestyle. The scale has a total of 16 items. The scale has three subscales: health beliefs, physical activity, and nutrition. The health beliefs subscale is composed of items 4, 5, 6, 11, 12, 13, and 16; the physical activity subscale includes items 2, 7, 9, 14, and 15; and the nutrition subscale comprises items 1, 3, 8, and 10. The scale, prepared according to the five-point Likert system, is answered on a scale of "1=Strongly Disagree, 5=Strongly Agree." A minimum of 16 and a maximum of 80 points can be obtained from the entire scale. An increase in the score obtained from the scale indicates an increase in adolescents' belief in healthy living.

    Time frame: 3 months

  6. Child's Attitude Towards Their Own Illness

    The Child's Attitude Toward Their Own Illness Scale is a 13-item measure developed to assess children's feelings and thoughts about having a chronic illness. Participants respond to the scale items using a 5-point Likert scale: "never, not often, sometimes, often, and very often." Items 1, 2, 3, 4, 5, 7, 9, 11, and 13 are reverse-coded. When evaluating the scale, the scores obtained from the 13 items are summed and divided by the number of items. The total score range is min: 1 to max: 5. Scores of 1 and 2 indicate a negative attitude, 3 indicates a neutral attitude, and 4 and 5 indicate a positive attitude.

    Time frame: 3 months

07

Study locations

1 site
  • Akdeniz University
    Antalya, Konyaaltı 07070, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2024 to primary completion in Mar 2025, 10 months.

Of 47 non-industry interventional studies with no phase under Gambling, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's 10 months is below that.

Counting every sponsor, half of 47 studies reached it within 16 months; a quarter within 10 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2025
First posted
Sep 9, 2025
StartActual
May 1, 2024
Primary completionActual
Mar 24, 2025
CompletionActual
May 1, 2025
Last update
Sep 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07162220
Lead sponsor
Akdeniz University
Collaborators
Sakarya Applied Sciences University, Tarsus University, Istanbul University
Responsible party
Banu Terzi (Principal Investigator, Akdeniz University) — Principal investigator
First posted
Sep 9, 2025
Start date
May 1, 2024
Primary completion
Mar 24, 2025
Completion
May 1, 2025
Last update
Sep 9, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion